ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 978,17
0,00%
Dow Jones
38 111,48
-0,86%
DAX
18 469,46
-0,24%
Brent Oil
81,77
-0,22%
Bitcoin
68 140,64
-0,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) Actualités

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EXAS
DateHeureSourceTitreSymboleSociété
28/05/202412h00Business WireExact Sciences to Participate in June Investor ConferencesNASDAQ:EXASEXACT Sciences Corporation
25/05/202413h32Business WireASCO®: Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von BehandlungsergebnissenNASDAQ:EXASEXACT Sciences Corporation
24/05/202418h46Business WireExact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO®NASDAQ:EXASEXACT Sciences Corporation
24/05/202412h05Business WireExact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®NASDAQ:EXASEXACT Sciences Corporation
22/05/202413h30Business WireExact Sciences Earns 2024 Great Place To Work® Certification™NASDAQ:EXASEXACT Sciences Corporation
21/05/202412h05Business WireCourt Ruling Enables Exact Sciences to Proceed with Lawsuit against GeneoscopyNASDAQ:EXASEXACT Sciences Corporation
20/05/202422h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
08/05/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXASEXACT Sciences Corporation
08/05/202423h08Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202423h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXASEXACT Sciences Corporation
08/05/202422h05Business WireExact Sciences Announces First-Quarter 2024 ResultsNASDAQ:EXASEXACT Sciences Corporation
08/05/202414h29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EXASEXACT Sciences Corporation
07/05/202414h00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
01/05/202412h00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
15/04/202412h00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
11/04/202412h00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
08/04/202418h05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
08/04/202412h00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
04/04/202412h05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
28/03/202411h00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
27/03/202413h05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
13/03/202422h03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
07/03/202413h59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
05/03/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
01/03/202421h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
26/02/202412h00Business WireExact Sciences to Participate in March Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
21/02/202423h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EXASEXACT Sciences Corporation
21/02/202422h05Business WireExact Sciences Announces Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
01/02/202412h00Business WireExact Sciences Schedules Fourth Quarter 2023 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
07/01/202422h30PR Newswire (US)Exact Sciences Announces Preliminary Fourth Quarter 2023 ResultsNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

Dernières Valeurs Consultées

TG
1KQ
Atlas Pearls
LSE
68TQ
Sthn.pac.fin4es
TG
42FB
AIML Innovations
COIN
BCDTETH
NYSE
FMDE
Fidelity Covingt
LSE
49GF
Southern.h 36
NASDAQ
BSVO
EA Bridgeway Omni Small ...
COIN
BXIOTETH
bXIOT Token
BIT
SFIB3L
SG ISSUER
USOTC
MDRNF
Modern PLT Based Foods (PK)
NASDAQ
IHTT
Interactive Health
TG
ME7
MEG Energy
BOV
NFTS11
Invsto VanckETF Crypto C...
AMEX
AGZ
iShares Agency
LSE
FRGP
Ish Fr Gv Bd Gb
NASDAQ
SCPH
scPharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés